Beranda › Kanker Ovarium › Montana › Billings
Uji klinis Kanker Ovarium di Billings, MT
9 studi untuk Kanker Ovarium mencari peserta di lokasi sekitar Billings (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Menerima pesertaFase 2
- Billings Clinic Cancer Center, Billings
Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
Menerima pesertaFase 3
- Research Site, Billings
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
Menerima pesertaFase 2
- Intermountain Health - Intermountain Health West End Clinic /ID# 278470, Billings
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Menerima pesertaFase 3
- Billings Clinic, Billings
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Menerima pesertaFase 2
- St. Vincent Regional Hospital - West End Clinic, Billings
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Menerima peserta
- Billings Clinic Cancer Center, Billings
- Saint Vincent Healthcare, Billings
- Saint Vincent Frontier Cancer Center, Billings
- dan 1 lainnya
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Menerima pesertaFase 3
- Billings Clinic Cancer Center, Billings
- Saint Vincent Healthcare, Billings
- Saint Vincent Frontier Cancer Center, Billings
- dan 1 lainnya
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
Menerima pesertaFase 3
- St. Vincent Gynecologic Oncology, Billings
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Menerima pesertaStudi observasional
- Massive Bio SYNERGY-AI site, Billings
Uji klinis Kanker Ovarium di kota lain
- Houston, TX89 studi
- New York City, NY69 studi
- Boston, MA61 studi
- Los Angeles, CA50 studi
- Nashville, TN49 studi
- Arlington, VA46 studi
- Philadelphia, PA44 studi
- Columbus, OH39 studi
- St. Louis, MO38 studi
- Chicago, IL36 studi
- San Antonio, TX31 studi
- Cleveland, OH30 studi
Studi lain di Billings
- Kanker Paru Non-Sel Kecil17 studi
- Kanker Prostat15 studi
- Kanker Paru13 studi
- Kanker Payudara10 studi
- Melanoma7 studi
- Leukemia Limfositik Kronis7 studi
- Leukemia Mieloid Akut7 studi
- Kanker Kandung Kemih6 studi
- Kanker Kolon6 studi
- Kanker Kolorektal6 studi
- Kanker Rektum5 studi
- Karsinoma Sel Skuamosa Kepala dan Leher4 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.